Patients from 105+ countries have trusted us
Join hundreds of happy patients who choose the right treatment and care.
Get A QuoteAllogeneic Bone Marrow Transplant Treatments in India
Allogeneic Bone Marrow Transplant
- Days In Hospital 30 days
- Outside Hospital Stay 60 days
- Success Rate %
Minimum Cost
$ 20000
Maximum Cost.
$ 25000
Most Asked Procedures
Overview of Allogeneic Bone Marrow Transplant in India
Patients who have damaged blood-forming cells in their bone marrow, either as a result of severe treatments like chemotherapy or a condition affecting the bone marrow or blood cells, are treated with allogeneic bone marrow therapy. In this procedure, the patient with damaged blood-forming cells receives a donation of healthy stem cells. In this procedure, the donor may be a member of the patient's family or a completely unrelated individual with the same genetic makeup.
Bone marrow allogeneic transplant usually causes more complications than the treatment conducted using a close relative as a donor. The procedure is also known as allogeneic stem cell transplant or allogeneic hematopoietic cell transplant. Though it can treat bone marrow disease and can even be used in case of severe cancer, this treatment is associated with certain risks and complications. In rare cases, bone marrow treatment might even be fatal due to transplant failure.
Therefore, it is clear that the benefits of this process exceed its risks and cons. Allogeneic treatment has the advantage of killing the rest of the cancer cells after the treatment. The success of allogeneic bone marrow treatment depends on the matching of the donor and patient, the condition of the recipient and the complications management after allogeneic treatment.
What Is Allogeneic Bone Marrow Transplant?
A bone marrow transplant consists of replacing the malfunctioning or destroyed bone marrow with healthy stem cells. An allogeneic transplant means obtaining healthy stem cells from a donor or umbilical cord blood, and transferring them to the patient.
This method can treat blood cancer, lymphoma, and other illnesses caused by disorders of the immune system associated with the blood. It means destroying unhealthy blood cells and replacing them with stem cells obtained from blood or bone marrow.
A bone marrow transplant can be useful to patients with malignant bone diseases and to those going through chemotherapy and experiencing bone marrow malfunction.
Also, it is a safe solution for patients with chronic immune deficiency in case of previous treatment failure.
However, there are risks involved in the procedure, which can occur before, during or after the procedure. Thus, it must be performed only by sufficiently experienced doctors and well-trained personnel.
Types of Allogeneic Bone Marrow Transplant:
Donor compatibility and stem cell origin can be used to classify allogeneic bone marrow transplants. Knowing these kinds makes it easier to choose the best course of action for every patient.
Based on Donor Compatibility
Matched Related Donor (MRD) Transplant: A related donor is someone from the family, usually a sibling. Since the HLA of the donor is very similar to that of the patient’s, the success rate of this type of transplant is higher than the success rate of other types of transplants.
Matched Unrelated Donor (MUD) Transplant: The donor does not have any familial ties with the patient, yet they still meet HLA requirements. Such donors are termed matched unrelated donors, and they are tracked mostly through national or international registers of bone marrow donations. The degree of compatibility is not so favourable yet enough for suitable bone marrow donations.
Haploidentical Transplant: A haploidentical donor is a family member who has HLA characteristics matching at least partially with the patient’s HLA (for example, the HLA profile of a parent or a child). The development of methods of bone marrow transplants has made this type of transplant more widely practised.
Based on Stem Cell Source
Bone Marrow Transplantation: In this procedure, stem cells are obtained directly from the donor's bone marrow, usually from the pelvic bones, via a surgical intervention under general anesthesia. The method is traditional, but some cases still require the application of this approach.
Peripheral Blood Stem Cell Transplantation: This is another method involving the extraction of stem cells from the blood of the donor. However, before they can be collected from the peripheral blood, stem cells must be expanded (i.e. grown under the stimulation from growth factors) and extracted using the apheresis procedure.
Cord Blood Stem Cell Transplant: Umbilical cord blood from a newborn is used for this type of stem cell transplant. The umbilical cord contains many stem cells. Although the number of cells obtained from the umbilical cord is smaller than in the previous two methods, the cord blood method has some advantages over the two mentioned due to a lower risk of graft-versus-host disease and more flexible HLA matching rules.
Procedure:
Evaluation & Donor Matching
Health Assessment: A patient undergoes a complete health assessment. For example, it includes blood analyses, scans, and bone marrow sample taking.
HLA Typing: Human Leukocyte typing is a process that aims to find a donor who matches either from a sibling or from random donor databases.
Conditioning & Preparation
Conditioning Therapy: Patients will be given aggressive chemotherapy (and sometimes radiation) to eradicate the diseased bone marrow, suppress the immune system to avoid rejection, and make room for the introduction of new stem cells.
Hospital Admission: Patients are admitted into a specialised unit designed for bone marrow transplantation with strict infection control procedures in place to avoid complications.
Donor Screening & Stem Cell Collection
Medical screening: Donors do this health checkup to make sure they’re eligible for the donation process, essentially.
Stem cell collection: The stem cells get collected either from the donor’s bone marrow or from peripheral blood, depending on what the protocol says.
Allogeneic Bone Marrow Transplant Procedure
Transplant Procedure & Engraftment
Stem Cell Infusion: The stem cells that were obtained are injected into the patient’s bloodstream through a central venous catheter in a process that is painless and takes a few hours, similar to a blood transfusion.
Cell Migration: After entering the bloodstream, stem cells go straight to the bone marrow, where they initiate their primary job of producing new blood cells.
Engraftment Timeline: The whole process of engraftment will take about 10 to 21 days, during which the patient is being monitored for complications.
Complications & Risk Management
Risks: The temporary weakening of the immune system predisposes the patient to infections, organ-specific complications, and Graft Versus Host Disease (GVHD), in which the donor immune cells attack the recipient’s tissues.
Preventative Care: In order to lower risks, medical teams use immunosuppressive drugs and antibiotics and monitor the patients for blood changes and organ function abnormalities.
Post-Operative Care & Recovery
Initial Recovery & Supportive Care
Protective Environment: This means close monitoring in a hospital setting, so we can minimise infection risks during that early, fragile recovery period.
Symptom Management: Things like nausea, vomiting, fatigue, and appetite loss are handled with supportive care. In some cases, blood transfusions are also used because the body needs a bit extra, you know.
Infection Prevention: Very strict precautions are necessary, including keeping personal hygiene up, steering clear of crowds, and taking prescribed medications exactly as ordered. It’s required because the infection risks are quite high right now.
Long-Term Recovery & GvHD Management
GvHD Prevention & Management: Graft-versus-Host Disease (GvHD), in which donor cells attack recipient tissues (usually the skin, liver, and intestines), is managed with immunosuppressive drugs and ongoing observation.
Immune System Rebuilding: As the new immune system progressively matures, immunisation is usually necessary six to twelve months after transplant.
Follow-Up & Lifestyle Care: Regular medical examinations, blood count monitoring, eating a balanced diet, and leading a healthy lifestyle are all necessary for long-term success.
Best Doctors in India
Cost of Allogeneic Bone Marrow Transplant in India
The price of allogeneic bone marrow transplants in India is lower than in most other countries. Indian patients can expect to pay between USD 13200 and USD 17600 for the procedures, while the cost for patients from other countries ranges between USD 2000 to USD 25000. Moreover, post-treatment medicine prices are also lower in India.
Top Hospitals in India
Indications of Allogeneic Bone Marrow Transplant:
Leukemia: Both acute and chronic kinds, where the bone marrow sort of makes abnormal white blood cells.
Lymphomas: Like Hodgkin and also non-Hodgkin lymphoma, cancers that start in the lymphatic system.
Aplastic Anemia: A situation where the bone marrow just can’t build enough blood cells.
Inherited Blood Disorders: Examples include sickle cell anemia and thalassemia; they mess with how hemoglobin is made or how it works.
Immune Deficiencies: When the immune system is weakened, or not acting in the usual way.
Myelodysplastic Syndromes: Problems linked to poorly made or not working blood cells.
Multiple Myeloma: A cancer of plasma cells found in the bone marrow.
Neuroblastoma: A cancer that grows from immature nerve cells, often in children.
The choice to go ahead with an allogeneic bone marrow transplant depends on several things, including the exact illness, where it is in its course, the patient’s general health, and whether a compatible donor is available. Overall, this kind of procedure can provide a curative path, basically by rebuilding normal hematopoiesis and immune function for people facing conditions that can be life-threatening.
Risk Factors:
Despite the many advantages, allogeneic bone marrow transplants are associated with certain risks and complications. This is why it is extremely important for patients and their healthcare providers to know about these risks in order to make educated decisions and cope with possible problems.
Graft-versus-host disease (GVHD): This is a condition that arises when donor immune cells (graft) attack the organs of the recipient (host) because they consider the recipient's body to be foreign. GVHD can be classified into two types, acute or chronic, and affects different organs like skin, liver, and gastrointestinal tract. The treatment usually includes the use of immunosuppressive drugs.
Infections: Conditioning and immunosuppressive treatment weaken the patient’s immune system, making them prone to infections caused by different microorganisms, including bacteria, viruses, and fungi. This problem can be solved by giving the patients antibiotics, antivirals, and antifungals and performing continuous monitoring of the disease.
Organ impairment: The pre-treatment phase can lead to organ impairment in organs including the heart, lungs, liver, and kidneys. Frequent organ function examinations are done to identify and treat possible problems quickly.
Infertility: The pre-treatment phase, and more specifically, if it involves radiation and chemotherapy, can cause infertility in both males and females. Patients get advice on possibilities of preserving fertility before the transplant.
Secondary cancers: The pre-treatment phase raises the possibility of acquiring secondary cancers, including skin cancers in the future. To reduce this likelihood, the patients undergo regular check-ups along with precautions including using sunscreen.
Long-term physiological effects: Such late complications may be seen as the development of osteoporosis, as well as dehydration, formation of cataracts, dysfunction of kidneys, and heart diseases. Regular follow-up is required to watch out for these possible long-term effects.
Mortality: Although progress has been made, the procedure still carries a risk of death due to complications such as acute GVHD syndrome, organ malfunction, and infections.